Nordic Capital and Astorg Acquire Cytel from New Mountain Capital
December 21, 2020
Nordic Capital and Astorg have agreed to jointly acquire Cytel Inc. from New Mountain Capital. Cytel, a Waltham, Massachusetts–based provider of clinical trial design software, biometrics services and advanced analytics with more than 1,500 employees, will continue to be led by CEO Josh Schultz while the new owners invest to accelerate product development and growth; terms were not disclosed.
- Buyers
- Nordic Capital, Astorg
- Targets
- Cytel Inc.
- Sellers
- New Mountain Capital
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BayPine to Acquire CenExel Clinical Research
April 14, 2025
Healthcare Services
BayPine entered into a definitive agreement to acquire CenExel Clinical Research, a nationwide clinical trial site network focused on complex therapeutic areas. After closing, BayPine will be the majority investor in CenExel alongside Webster Equity Partners, which will retain a minority stake, with management continuing to hold equity.
-
Astorg Acquires Majority Stake in Steliau
February 26, 2024
Industrial Services
Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.
-
Nordic Capital Becomes Major Shareholder in Equashield
October 7, 2022
Medical Devices
Nordic Capital has made a significant minority investment in Equashield to support the company's next phase of growth and global expansion. The partnership will help Equashield commercialize its automated compounding systems and scale its closed system transfer device (CSTD) business across healthcare markets.
-
Norstella and Citeline Merge to Create $5B Global Pharma Technology Company
June 28, 2022
Data & Analytics
Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).
-
SilverSky Acquires Cygilant
January 10, 2022
Cybersecurity
SilverSky has acquired Burlington, Massachusetts-based Cygilant, adding the target's Belfast-based SOC and Ph.D.-level cybersecurity and data-research talent. The deal expands SilverSky's geographic footprint into the UK/Europe and strengthens its managed detection and response (MDR) capabilities.
-
Astorg Joins Nordic Capital and Novo Holdings in Recapitalization of ERT
October 21, 2019
Healthcare Services
Astorg will invest in eResearchTechnology, Inc. (ERT), joining existing owners Nordic Capital, Novo Holdings A/S and the ERT management team in a broadened ownership group. The investors will support continued development of ERT's clinical trial technology platform, expand operational capabilities, and pursue selective add-on acquisitions to drive future growth; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.